Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+6.48%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$76.3B
AUM Growth
+$3.71B
(+5.1%)
Cap. Flow
-$8.94B
Cap. Flow
% of AUM
-11.71%
Top 10 Holdings %
Top 10 Hldgs %
21.64%
Holding
2,671
New
223
Increased
746
Reduced
756
Closed
309
Top Buys
| 1 |
Norfolk Southern
NSC
|
+$289M |
| 2 |
Union Pacific
UNP
|
+$247M |
| 3 |
UnitedHealth
UNH
|
+$246M |
| 4 |
CyberArk
CYBR
|
+$171M |
| 5 |
Chevron
CVX
|
+$161M |
Top Sells
| 1 |
Analog Devices
ADI
|
+$278M |
| 2 |
Meta Platforms (Facebook)
META
|
+$199M |
| 3 |
Aon
AON
|
+$188M |
| 4 |
PNC Financial Services
PNC
|
+$131M |
| 5 |
PayPal
PYPL
|
+$125M |
Sector Composition
| 1 | Technology | 18.85% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.89% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Neogen
NEOG
$1.25B
| $2.59M | ﹤0.01% |
139,927
+1,644
| +1% | +$30.4K |
|
|
HQL
652
abrdn Life Sciences Investors
HQL
$412M
| $2.58M | ﹤0.01% |
185,332
| – | – |
|
653
Coherus Oncology, Inc. Common Stock
CHRS
$153M
| $2.58M | ﹤0.01% |
377,333
+59,611
| +19% | +$408K |
|
654
FedEx
FDX
$54.2B
| $2.55M | ﹤0.01% |
11,176
+2,499
| +29% | +$571K |
|
655
Moderna
MRNA
$9.78B
| $2.55M | ﹤0.01% |
16,593
+510
| +3% | +$78.3K |
|
656
EOG Resources
EOG
$65.4B
| $2.5M | ﹤0.01% |
21,829
+28
| +0.1% | +$3.21K |
|
657
Ross Stores
ROST
$49.2B
| $2.5M | ﹤0.01% |
23,563
+22,416
| +1,954% | +$2.38M |
|
658
BlackRock Health Sciences Trust II
BMEZ
$897M
| $2.41M | ﹤0.01% |
144,466
-20
| -0% | -$334 |
|
659
Premier
PINC
$2.23B
| $2.41M | ﹤0.01% |
74,587
-2,018
| -3% | -$65.3K |
|
660
iShares US Treasury Bond ETF
GOVT
$28.3B
| – | – |
0
| – | -$1.89M |
|
661
Lufax Holding
LU
$2.59B
| $2.4M | ﹤0.01% |
+293,973
| New | +$2.4M |
|
662
Insulet
PODD
$24B
| $2.39M | ﹤0.01% |
7,493
-346
| -4% | -$110K |
|
663
Jack Henry & Associates
JKHY
$11.7B
| $2.39M | ﹤0.01% |
15,845
-356
| -2% | -$53.7K |
|
|
CDMO
664
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.38M | ﹤0.01% |
127,008
-77,656
| -38% | -$1.46M |
|
665
J.M. Smucker
SJM
$11.8B
| $2.37M | ﹤0.01% |
15,072
-799
| -5% | -$126K |
|
666
TEGNA Inc
TGNA
$3.39B
| $2.37M | ﹤0.01% |
+140,226
| New | +$2.37M |
|
667
FirstEnergy
FE
$24.8B
| $2.37M | ﹤0.01% |
59,154
-62,536
| -51% | -$2.5M |
|
|
GTM
668
ZoomInfo Technologies
GTM
$3.62B
| $2.36M | ﹤0.01% |
95,696
+50,392
| +111% | +$1.24M |
|
669
Schlumberger
SLB
$54.4B
| $2.36M | ﹤0.01% |
48,051
+670
| +1% | +$32.9K |
|
670
Emcor
EME
$28.9B
| $2.34M | ﹤0.01% |
14,381
-59,890
| -81% | -$9.73M |
|
671
Apellis Pharmaceuticals
APLS
$3.25B
| $2.33M | ﹤0.01% |
35,304
-49,516
| -58% | -$3.27M |
|
672
Regency Centers
REG
$13B
| $2.33M | ﹤0.01% |
38,058
+31,655
| +494% | +$1.94M |
|
673
MaxCyte
MXCT
$155M
| $2.31M | ﹤0.01% |
467,130
+110,069
| +31% | +$545K |
|
674
Recursion Pharmaceuticals
RXRX
$2.17B
| $2.3M | ﹤0.01% |
345,540
+181,631
| +111% | +$1.21M |
|
675
Maxeon Solar Technologies
MAXN
$67.4M
| $2.29M | ﹤0.01% |
864
-3,089
| -78% | -$8.2M |
|